Search Results - "Hardt‐Lindberg, Søren"
-
1
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Published in The New England journal of medicine (14-12-2023)“…In a trial in patients with cardiovascular disease and overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major…”
Get full text
Journal Article -
2
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics
Published in Obesity (Silver Spring, Md.) (01-01-2023)“…Objective This paper describes the baseline characteristics of the Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity…”
Get full text
Journal Article -
3
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths: An Analysis From the SELECT Trial
Published in Journal of the American College of Cardiology (22-10-2024)“…Patients with overweight and obesity are at increased risk of death from multiple causes, including cardiovascular (CV) death, with few therapies proven to…”
Get full text
Journal Article -
4
Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the select trial
Published in Atherosclerosis (01-08-2024)Get full text
Journal Article -
5
HERMES: Effects Of Ziltivekimab Versus Placebo On Morbidity And Mortality In Patients With Heart Failure With Mildly Reduced Or Preserved Ejection Fraction And Systemic Inflammation
Published in Journal of cardiac failure (01-01-2024)“…Inflammation is a central pathophysiological process in heart failure with preserved (HFpEF) and mildly reduced ejection fraction (HFmrEF). Il-6, a…”
Get full text
Journal Article -
6
The Effect of Semaglutide on Mortality and COVID-19–Related Deaths
Published in Journal of the American College of Cardiology (22-10-2024)“…Patients with overweight and obesity are at increased risk of death from multiple causes, including cardiovascular (CV) death, with few therapies proven to…”
Get full text
Journal Article -
7
Semaglutide and cardiovascular outcomes in patients with overweight or obesity who do not have diabetes
Published in Obesity research & clinical practice (01-09-2024)Get full text
Journal Article -
8
209 - Semaglutide and cardiovascular outcomes in patients with overweight or obesity who do not have diabetes
Published in Obesity research & clinical practice (01-09-2024)Get full text
Journal Article